<prompt> The antiretroviral drug that can bind to both CCR2 and CCR5 is -CenicrivirocVicrivirocIpalizumabBevirimat  <response>: CenicrivirocCenicrivirocbinds to both CCR2 and CCR5. It is a fusion entry inhibitor. CCR2 binding may contribute to anti-inflammatory effect.Vicriviroc binds to CCR5. It is a fusion entry inhibitor. Not found to be efficacious in clinical trials, hence further trials were discontinued.Ipalizumab is a monoclonal antibody against CD4. It is a fusion entry inhibitorBevirimat is a maturation inhibitor. It binds to gag protein 